The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) ...

Christopher M. Kramer, MD, FACC, received his medical degree from the University of California, San Francisco School of Medicine, and completed his residency and chief residency in internal medicine, ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

Chest pain is one of the most common reasons that people seek medical care. This guideline was developed for the evaluation of acute or stable chest pain in outpatient and emergency department ...

The Acute Coronary Syndromes Clinical Topic Collection gathers the latest guidelines, news, JACC articles, education, meetings and clinical images pertaining to its cardiovascular topical area — all ...

In this week’s View, Dr. Eagle looks at the new ACC/AHA guideline for prevention, detection, evaluation and management of high blood pressure (BP). He then discusses new-onset right bundle branch ...

The 2025 ACC/AHA Acute Coronary Syndrome (ACS) Guideline clarifies diagnostic distinctions using electrocardiogram changes, troponin levels, and imaging tools such as coronary CT angiography and ...

More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and death, according to a study in JACC, the flagship journal of the American ...

We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. The updated ASCVD Risk Estimator Plus uses up-to-date ACC clinical policy and user ...

I am honored to serve as the new Chair of this dynamic community, and I am excited to work alongside all of you. As cardiovascular professionals dedicated to advancing our field, our collective ...

Within the last 2 decades, the number of patients with diabetes quadrupled from 108 million to 422 million in 2014. 1 It is estimated that the burden of diabetes will continue to grow owing to the ...

The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) due to long-term ...